UNSPSC 85552939: Destruction of left lacrimal gland, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to destruction of left lacrimal gland, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 085W3ZZ

UNSPSC 85552939 Destruction of left lacrimal gland, percutaneous approach is a Commodity code that does not reflect the scope of recent state and local procurement activity tagged under it. The recent opportunities associated with this code—independent medical evaluation services for disability retirement determinations, surgical procedure carve-out benefits for municipal employees, occupational medical surveillance for state ferry workers, emergency and specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing—span occupational health, employee benefits administration, and clinical workforce services. None of these solicitations involve destruction of a lacrimal gland or any ophthalmologic surgical procedure. The code appears to be a taxonomy mismatch in the state and local procurement system, suggesting either miscoding of opportunities at source or a systematic labeling error.

The issuing bodies across these opportunities include a city retirement office (Phoenix), municipal human resources departments (Long Beach), a state transportation agency (Washington State Department of Transportation), a county juvenile probation department (Harris County), a county board of commissioners (Collier County, Florida), and a county health system (Santa Clara, California). The geographic spread covers Arizona, California, Florida, Texas, and Washington. Because the recent opportunities are substantively unrelated to the code's nominal clinical scope, the code does not represent a coherent or actionable procurement category for state and local contract pursuit at this time.